- This event has passed.
BRI Live Event Series with Rafael Fonseca, M.D., Interim Executive Director, Mayo Clinic Comprehensive Cancer Center – ““Medicine in the post COVID era – the Genie is out of the bottle!”
May 29, 2020 @ 12:00 pm - 1:00 pm
Dr. Rafael Fonseca of the Mayo Clinic joined Benjamin Rush Institute on May 29, 2020 to talk about healthcare in the post-Covid world. Watch the full video below.
Rafael Fonseca, MD, is the Getz Family Professor of Cancer, Professor of Medicine, Chair of the Department of Internal Medicine, Director for Innovation and Transformational Relationships, Interim Executive Director of the Mayo Clinic Comprehensive Cancer Center, and a consultant in the Division of Hematology/Oncology at the Mayo Clinic in Arizona. He earned his MD at Universidad Anahuac, Mexico. He completed a residency in internal medicine at the University of Miami, FL, and a fellowship in hematology and medical oncology at Mayo Graduate School of Medicine, Rochester, MN. He was named a clinical investigator for the Damon Runyon Cancer Research Fund. He is a visiting healthcare fellow at the Goldwater Institute. Dr Fonseca’s practice has focused on the diagnosis and treatment of plasma cell disorders and leading the multiple myeloma team in its efforts to develop a better understanding of the disease and its impact on patients. In his laboratory, Dr Fonseca has led his team of researchers in concentrating on the genetic nature of the clonal cells of plasma cell disorders, myeloma bone disease, prognostic markers, and development of new therapies for the disease.
Throughout his training and career, Dr. Fonseca has received numerous awards and honors, including the Damon Runyon-Walter Winchell Clinical Investigator Award, and the International Waldenström Macroglobulinemia Research Award. Most notably, he is a Mayo Clinic Distinguished Investigator, the highest academic distinction given to investigators at his institution. Dr. Fonseca holds memberships and serves in positions for organizations such as the American Society of Clinical Oncology, American Society of Hematology, American Association for Cancer Research, and the International Myeloma Society. Dr. Fonseca serves as reviewer and in editorial capacities for medical publications. He has given many national and international presentations as a visiting professor, and has authored numerous articles.